xylazine has been researched along with Adrenocortical Hyperfunction in 1 studies
Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.
Adrenocortical Hyperfunction: Excess production of ADRENAL CORTEX HORMONES such as ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and/or ANDROSTENEDIONE. Hyperadrenal syndromes include CUSHING SYNDROME; HYPERALDOSTERONISM; and VIRILISM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Before treatment of the hyperadrenocorticism, no significant increase in growth hormone concentration occurred in any of the dogs following the administration of xylazine." | 1.26 | Suppression of growth hormone secretion in spontaneous canine hyperadrenocorticism and its reversal after treatment. ( Altszuler, N; Peterson, ME, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peterson, ME | 1 |
| Altszuler, N | 1 |
1 other study available for xylazine and Adrenocortical Hyperfunction
| Article | Year |
|---|---|
Suppression of growth hormone secretion in spontaneous canine hyperadrenocorticism and its reversal after treatment.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocortical Hyperfunction; Animals; Cushing Syndrome; Dog Disea | 1981 |